Dr. Reddy's Laboratories Ltd (RDY) vs Viatris Inc. (VTRS)
- Dr. Reddy's Laboratories Ltd RDY 13.05 +1.16%
- Viatris Inc. VTRS 18.66 +2.41%
Dr. Reddy's Laboratories Ltd and Viatris Inc. are both Drug Manufacturers Specialty & Generic companies. Viatris Inc. is the larger, with a market value of $20.9B against $10.7B — 1.9× the size. Viatris Inc. has negative trailing earnings, so its P/E is not meaningful; Dr. Reddy's Laboratories Ltd trades at 32.9×. Viatris Inc. grew revenue faster over the last twelve months: 4.40% against −11.6%. Dr. Reddy's Laboratories Ltd has the higher net margin (9.81% vs −2.79%) and the higher return on invested capital (5.89% vs −0.20%). Only Viatris Inc. pays a dividend (2.57%). Across the 22 metrics below, Dr. Reddy's Laboratories Ltd leads on 13 and Viatris Inc. on 9.
Valuation
Profitability
| Metric | RDY | VTRS | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | 50.00% | 34.83% | 53.94% |
| Operating margin | 10.91% | (0.59%) | 0.00% |
| Net margin | 9.81% | (2.79%) | 0.00% |
| Free cash flow margin | 4.05% | 12.83% | 0.00% |
| Return on equity | 8.21% | (2.75%) | (0.40%) |
| Return on assets | 5.55% | (1.12%) | (3.32%) |
| Return on invested capital | 5.89% | (0.20%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack